Associations of homocysteine status and homocysteine metabolism enzyme polymorphisms with hypertension and dyslipidemia in a Chinese hypertensive population

References

• Weiwei C, Runlin G, Lisheng L, Manlu Z, Wen W, Yongjun W, Zhaosu W, Huijun L, Zhe Z, Lixin J, et al. Outline of the report on cardiovascular diseases in China, 2014. Eur Heart J Suppl. 2016;18(SupplF):F2–F11. doi:10.1093/eurheartj/suw1030. Epub 2016 May 1024.
   PubMedGoogle Scholar
• Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013;128(11):1189–97. Epub 002013 Sep 002673. doi:10.1161/CIRCULATIONAHA.113.002671.
   PubMed Web of Science ®Google Scholar
• Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324(17):1149–55. doi:10.1056/NEJM199104253241701.
   PubMed Web of Science ®Google Scholar
• Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1(5):228–37.
   PubMed Web of Science ®Google Scholar
• Tyagi N, Moshal KS, Ovechkin AV, Rodriguez W, Steed M, Henderson B, Roberts AM, Joshua IG, Tyagi SC. Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem. 2005;96(4):665–71. doi:10.1002/jcb.20578.
   PubMed Web of Science ®Google Scholar
• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6. DOI:10.1186/1475-2891-1114-1186.
   PubMed Web of Science ®Google Scholar
• Chen H, Sun Y, Wang X, Si Q, Yao W, Wan Z. Association of cardiometabolic risk profile with prehypertension accompany hyperhomocysteinaemia. Clin Exp Hypertens. 2015;37(3):218–22. doi:10.3109/10641963.2014.939276.
   PubMed Web of Science ®Google Scholar
• Momin M, Fan F, Li J, Qin X, Jia J, Qi L, Zhang Y, Huo Y. Associations of plasma homocysteine levels with peripheral systolic blood pressure and noninvasive central systolic blood pressure in a community-based Chinese population. Sci Rep. 2017;7(1):6316. doi:10.1038/s41598-017-06611-3.
   PubMedGoogle Scholar
• Momin M, Jia J, Fan F, Li J, Dou J, Chen D, Huo Y, Zhang Y. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids Health Dis. 2017;16(1):54. doi:10.1186/s12944-017-0565-8.
   PubMedGoogle Scholar
• Vinukonda G, Mohammad NS, Jain JMN, Chintakindi KP, Akella RRD. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians. Clin Chim Acta. 2009;405(1–2):127–31. doi:10.1016/j.cca.2009.04.015.
   PubMed Web of Science ®Google Scholar
• Tang Z, Xiao L, Wang JQ, Zhang T. Analysis of metabolism-related indicators and MTHFR gene polymorphism in patients with H-type hypertension. Minerva Med. 2017;108(2):103–07. doi:10.23736/S0026-4806.16.04951-X.
   PubMed Web of Science ®Google Scholar
• Li WX, Lv WW, Dai SX, Pan ML, Huang JF. Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study. Lipids Health Dis. 2015;14:101. doi:10.1186/s12944-015-0099-x.
   PubMed Web of Science ®Google Scholar
• Bahadir A, Eroz R, Turker Y. Does the MTHFR C677T gene polymorphism indicate cardiovascular disease risk in type 2 diabetes mellitus patients? Anatol J Cardiol. 2015;15(7):524–30. doi:10.5152/akd.2014.5555.
   PubMed Web of Science ®Google Scholar
• Joint Committee for the Development of guidelines for prevention and treatment of dyslipidemia in adults.[Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007:35(5):390–419.
   PubMedGoogle Scholar
• Chang Y, Li Y, Guo X, Chen Y, Dai D, Sun Y. The prevalence of hypertension accompanied by high homocysteine and its risk factors in a rural population: A cross-sectional study from Northeast China. Int J Environ Res Public Health. 2017;14(4). doi:10.3390/ijerph14040376.
   Web of Science ®Google Scholar
• Abudureheman K, Mahemuti A, Xia YN, Hu XM. Association between gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine in Uygur patients with venous thromboembolism. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40(12):1030–36.
   PubMedGoogle Scholar
• Wang Y, Xu X, Huo Y, Liu D, Cui Y, Liu Z, Zhao Z, Xu X, Liu L, Li X, et al. Predicting hyperhomocysteinemia by methylenetetrahydrofolate reductase C677T polymorphism in Chinese patients with hypertension. Clin Appl Thromb Hemost. 2015;21(7):661–66. doi:10.1177/1076029613519849.
   PubMed Web of Science ®Google Scholar
• Markan S, Sachdeva M, Sehrawat BS, Kumari S, Jain S, Mthfr KM. 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem. 2007;302(1–2):125–31. doi:10.1007/s11010-007-9434-5.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang Y, Wang H, Ouyang J, Munila A, Kalibinuer Y, Yang M. Association of plasma homocysteine level and polymorphism of methione synthase reductase gene with essential hypertension in ethnic Uyghurs and Hans from Xinjiang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015;32(4):548–53. doi:10.3760/cma.j.issn.1003-9406.2015.04.022.
   PubMedGoogle Scholar
• Han L, Liu Y, Wang C, Tang L, Feng X, Astell-Burt T, Wen Q, Duan D, Lu N, Xu G, et al. Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review. Clin Nutr. 2017;36(5):1215–30. doi:10.1016/j.clnu.2016.11.011.
   PubMed Web of Science ®Google Scholar
• Das M, Ghose M, Borah NC, Choudhury N. A community based study of the relationship between homocysteine and some of the life style factors. Indian J Clin Biochem. 2010;25(3):295–301. doi:10.1007/s12291-010-0044-8.
   PubMedGoogle Scholar
• Husemoen LL, Linneberg A, Fenger M, Thuesen BH, Jorgensen T. Changes in lifestyle, biological risk factors and total homocysteine in relation to MTHFR C677T genotype: a 5-year follow-up study. Eur J Clin Nutr. 2009;63(10):1233–40. doi:10.1038/ejcn.2009.59.
   PubMed Web of Science ®Google Scholar
• Li WX, Liao P, Hu CY, Cheng F, Zhang T, Sun YY, Tang L, Wang MM, Liu KS, Liu D, et al. Interactions of methylenetetrahydrofolate reductase gene polymorphisms, folate, and homocysteine on blood pressure in a Chinese hypertensive population. Clin Lab. 2017;63(4):817–25. doi:10.7754/Clin.Lab.2016.160918.
   PubMed Web of Science ®Google Scholar
• Yucel K, Bekci TT, Taner A, Kayrak M, Korucu EN, Unlu A. Homocysteine levels in patients with masked hypertension. Anadolu Kardiyol Derg. 2014;14(4):357–62. doi:10.5152/akd.2014.4689.
   PubMedGoogle Scholar
• Li S, Zhu J, Wu L, Peng L, Luo Y, Zhao Y, Dong R, Chen L, Tang X, Liu J. The association between plasma homocysteine and ambulatory blood pressure variability in patients with untreated hypertension. Clin Chim Acta. 2018;477:32–38. doi:10.1016/j.cca.2017.11.042.
   PubMed Web of Science ®Google Scholar
• Dong YF, Zhan BM, Hao QY, Ruan ZH, Xu ZX, Deng M, Chen DW, Zou YQ, Chen J, Li P, et al. Plasma homocysteine levels are associated with circadian blood pressure variation in Chinese hypertensive adults. Am J Hypertens. 2017;30(12):1203–10. doi:10.1093/ajh/hpx116.
   PubMed Web of Science ®Google Scholar
• Qian X, Lu Z, Tan M, Liu H, Lu D. A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet. 2007;15(12):1239–45. doi:10.1038/sj.ejhg.5201914.
   PubMed Web of Science ®Google Scholar
• Xu H, Zheng H, Shen Y, Huang J, Luo M. Polymorphism of the methylenetetrahydrofolate reductase gene C677T and its influence on the antihypertensive and vascular protective effects of short-term lercanidipine treatment. Gene. 2012;500(2):207–10. doi:10.1016/j.gene.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Jiang S, Yu Y, Venners SA, Zhang Y, Xing H, Wang X, Xu X. Effects of MTHFR and MS gene polymorphisms on baseline blood pressure and Benazepril effectiveness in Chinese hypertensive patients. J Hum Hypertens. 2011;25(3):172–77. doi:10.1038/jhh.2010.50.
   PubMed Web of Science ®Google Scholar
• Lin PT, Cheng CH, Wei JC, Huang YC. Low plasma pyridoxal 5ʹ-phosphate concentration and MTHFR 677C–>T genotypes are associated with increased risk of hypertension. Int J Vitam Nutr Res. 2008;78(1):33–40. doi:10.1024/0300-9831.78.1.33.
   PubMed Web of Science ®Google Scholar
• Fowdar JY, Lason MV, Szvetko AL, Lea RA, Griffiths LR. Investigation of homocysteine-pathway-related variants in essential hypertension. Int J Hypertens. 2012;2012:190923. doi:10.1155/2012/190923.
   PubMedGoogle Scholar
• Hirche F, Schroder A, Knoth B, Stangl GI, Eder K. Methionine-induced elevation of plasma homocysteine concentration is associated with an increase of plasma cholesterol in adult rats. Ann Nutr Metab. 2006;50(2):139–46. doi:10.1159/000090635.
   PubMed Web of Science ®Google Scholar
• Baszczuk A, Musialik K, Kopczynski J, Thielemann A, Kopczynski Z, Kesy L, Dopierala G. Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension. Adv Med Sci. 2014;59(1):68–73. doi:10.1016/j.advms.2013.08.001.
   PubMed Web of Science ®Google Scholar
• Raina JK, Sharma M, Panjaliya RK, Bhagat M, Sharma R, Bakaya A, Kumar P. Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms and associated risk of cardiovascular diseases: A study from Jammu region. Indian Heart J. 2016;68(3):421–30. doi:10.1016/j.ihj.2016.02.009.
   PubMedGoogle Scholar
• Marosi K, Agota A, Vegh V, Joo JG, Langmar Z, Kriszbacher I, Nagy ZB. [The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension]. Orv Hetil. 2012;153(12):445–53. doi:10.1556/OH.2012.29326.
   PubMedGoogle Scholar
• Li Z, Yadav U, Mahemuti A, Tang BP, Upur H. Association of MTHFR genetic polymorphisms with venous thromboembolism in Uyghur population in Xinjiang, China. Int J Clin Exp Med. 2015;8(10):17703–11.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yin RX, Liu WY, Miao L, Wu DF, Aung LH, Hu XJ, Cao XL, Wu JZ, Pan SL. Association of methylenetetrahydrofolate reductase C677T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Lipids Health Dis. 2010;9:123. doi:10.1186/1476-511X-9-123.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li K, Venners SA, Hsu YH, Jiang S, Weinstock J, Wang B, Tang G, Individual XX. Joint associations of methylenetetrahydrofolate reductase C677T genotype and plasma homocysteine with dyslipidemia in a Chinese population with hypertension. Clin Appl Thromb Hemost. 2017;23(3):287–93. doi:10.1177/1076029615609686.
   PubMed Web of Science ®Google Scholar
• Morais CC, Alves MC, Augusto EM, Abdalla DS, Horst MA, Cominetti C. The MTHFR C677T polymorphism is related to plasma concentration of oxidized low-density lipoprotein in adolescents with cardiovascular risk factors. J Nutrigenet Nutrigenomics. 2015;8(3):105–13. doi:10.1159/000439218.
   PubMed Web of Science ®Google Scholar
• Chang YH, Fu WM, Wu YH, Yeh CJ, Huang CN, Shiau MY. Prevalence of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Taiwanese patients with Type 2 diabetic mellitus. Clin Biochem. 2011;44(17–18):1370–74. Epub 2011 Oct 1378. doi:10.1016/j.clinbiochem.2011.09.020.
   PubMed Web of Science ®Google Scholar
• Huang L, Song XM, Zhu WL, Li Y. Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects. Biomed Environ Sci. 2008;21(6):514–20. doi:10.1016/S0895-3988(09)60011-8.
   PubMed Web of Science ®Google Scholar
• Jiang S, Zhao R, Pan M, Venners SA, Zhong G, Hsu YH. Associations of MTHFR and MTRR polymorphisms with serum lipid levels in Chinese hypertensive patients. Clin Appl Thromb Hemost. 2014;20(4):400–10. doi:10.1177/1076029612467226.
   PubMed Web of Science ®Google Scholar